We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+19.23%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.08B
AUM Growth
+$128M
Cap. Flow
-$13.4M
Cap. Flow %
-1.24%
Top 10 Hldgs %
65.89%
Holding
283
New
55
Increased
41
Reduced
42
Closed
144

Sector Composition

Rank Sector Weight
1 Healthcare 60.27%
2 Real Estate 10.75%
3 Technology 10.08%
4 Industrials 8.07%
5 Consumer Discretionary 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
176
First American
FAF
$7.66B
-77,119
Closed -$3.99M
FDS icon
177
Factset
FDS
$9.36B
-12,386
Closed -$2.45M
FICO icon
178
Fair Isaac
FICO
$24.3B
-21,429
Closed -$4.14M
GD icon
179
General Dynamics
GD
$104B
-16,000
Closed -$2.98M
GILD icon
180
Gilead Sciences
GILD
$162B
-20,840
Closed -$1.48M
GIS icon
181
General Mills
GIS
$19.1B
-50,000
Closed -$2.21M
GPN icon
182
Global Payments
GPN
$23B
-43,964
Closed -$4.9M
HIG icon
183
Hartford Financial Services
HIG
$38.9B
-69,370
Closed -$3.55M
HLIO icon
184
Helios Technologies
HLIO
$2.57B
-43,586
Closed -$2.1M
HOG icon
185
Harley-Davidson
HOG
$2.58B
-55,971
Closed -$2.35M
HRI icon
186
Herc Holdings
HRI
$5.02B
-10,121
Closed -$570K
HRTX icon
187
Heron Therapeutics
HRTX
$93.9M
-75,645
Closed -$2.94M
IART icon
188
Integra LifeSciences
IART
$1.29B
-23,972
Closed -$1.54M
ICE icon
189
Intercontinental Exchange
ICE
$85.6B
-55,100
Closed -$4.05M
IONS icon
190
Ionis Pharmaceuticals
IONS
$8.6B
-21,450
Closed -$894K
IRWD icon
191
Ironwood Pharmaceuticals
IRWD
$696M
-36,536
Closed -$585K
JD icon
192
JD.com
JD
$44.6B
-45,000
Closed -$1.75M
JEF icon
193
Jefferies Financial Group
JEF
$12.6B
-485,208
Closed -$9.88M
KALA icon
194
KALA BIO
KALA
$14.1M
-37
Closed -$1.26M
KURA icon
195
Kura Oncology
KURA
$800M
-49,121
Closed -$894K
LDOS icon
196
Leidos
LDOS
$14.5B
-25,000
Closed -$1.48M
LLY icon
197
Eli Lilly
LLY
$1.02T
-11,786
Closed -$1.01M
LUV icon
198
Southwest Airlines
LUV
$22B
-85,984
Closed -$4.38M
LXRX icon
199
Lexicon Pharmaceuticals
LXRX
$1.03B
-63,125
Closed -$758K
MAN icon
200
ManpowerGroup
MAN
$2.44B
-17,500
Closed -$1.51M

Similar funds

Crestline Management's Q3 2018 Portfolio in Review

As of Q3 2018, Crestline Management held 283 positions worth $1.08B, up 13% from $952M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Crestline Management's Q3 2018 filing shows 55 new, 41 increased, 42 reduced and 144 closed positions. Its largest new stake was Aquestive Therapeutics: 11,503,294 shares worth $201M. The largest sale was Athene Holding Ltd. Class A Common Shares, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 43% a quarter earlier, followed by Real Estate and Technology.

  • Crestline Management's largest Q3 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $201M.
  • Crestline Management added most to Red Hat Inc in Q3 2018, an estimated $6.11M increase.
  • Crestline Management's biggest Q3 2018 reduction was Norwegian Cruise Line, cutting an estimated $4.27M.
  • Crestline Management fully exited Athene Holding Ltd. Class A Common Shares in Q3 2018, selling an estimated $11.1M.
  • Crestline Management's ten largest holdings make up 66% of its $1.08B portfolio in Q3 2018.
  • Crestline Management opened 55 new positions and closed 144 in Q3 2018.
  • Crestline Management's portfolio value rose 13% quarter-over-quarter to $1.08B.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.